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ABSTRACT 
Objective: The objective of present work was to evaluate wound healing potential of pongamia glabra, piper nigrum and momordica 
charantia using as herbal ointment formulation on albino rats using burn wound model.  All the plant has the rich source of alkaloid, 
glycoside, tannins, carbohydrates, saponins, flavonoids, proteins and amino acids content and were used as anti-diabetic, anti-inflammatory, 
antitumor, anti-malarial and having wound healing potential. Materials and Methods: Extract of all three plants has been separated by the 
Soxhlet extraction. Herbal ointment formulation has been prepared by mixing the extract of momordica charantia, pongamia glabra and 
piper nigrum with the wool fat and paraffin. Burn wound model has been utilized for the evaluation of wound healing potential. 
Histopathological evaluation has been also carried-out for the physical verification wound healing potential. Results and Conclusion: The 
studies on burn wound healing model reveals that all twelve groups showed decreased wound area on the time and there was no mortality 
observed in the course of study. Discussion: These studies have indicated that herbal ointment formulation of pongamia glabra, piper 
nigrum and momordica charantia has been utilized for wound healing and it is safer for topical application. No toxicity and mortality have 
been observed during the experimental tenure.   
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INTRODUCTION 
Wounds are the physical injuries resulting in opening or 
breaking of the skin and appropriate method for healing of 
wounds is essential for the restoration of disrupted 
anatomical continuity and disturbed functional status of 
the skin. In pathology, it specifically refers to sharp injury, 
which damages the dermis of the skin. Healing of wounds 
starts from the moment of injury and can continue for 
varying periods of time depending on the extent of 
wounding and the process can be broadly categorized into 
three stages; inflammatory phase, proliferate phase and 
finally the remodeling phase which ultimately determines 
the strength and appearance of the healed tissue. Wound 
healing is a complex regeneration process, which is 
characterized by intercalating degradation and re-
assembly of connective tissue and epidermal layer. Wound 
healing is a complex and dynamic process with the wound 
environment changing with the changing health status of 
the individual or it is the body natural process of 
regenerating dermal and epidermal tissues. Hyperglycemia 
has suppressed cell proliferation collagen production1. 
Pongamia glabra (Figure 1) belong to Fabaceae family2. 
Fruit contains furano-flavonoids, coumestan and 
pongacoumestan. P. glabra has been reported to contain a 
large number of furano flavonoids e.g. karanjin, pongapin, 
kanjone, pongamol. It used as bacteriocidal activity against 
V. cholerae and E. coli, and also used as anti-inflammatory 
and antipyretic properties3. 
Piper nigrum (Figure 2) belonging to family piperaceae4. 
The fruits have small globose drupe and was known as a 
peppercorn when dried. Pepper plants grow easily in the 
shade and require little maintenance until harvest, so they 
are frequently cultivated for supplemental income on even 
small farms. 
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Figure 1: Leaves, flowers and seeds of Pongamia glabra 
    
Figure 2: Unripe and ripe seeds of Piper nigrum 
Black pepper is used to improve digestion, stimulate 
appetite and treat gastrointestinal problems. It is also used 
to treat cold, cough and sore throats. Antioxidant active 
chemicals isolated from black pepper include camphene, 
carvacrol, eugenol, myrcene myristic-acid, myristicin, 
palmitic-acid and ubiquinone and were responsible for 
aroma, pungency and medicinal property of the black 
pepper.  
Momordica charantia belong to Cucurbitaceae family5. The 
fruit has a distinct warty looking exterior and an oblong 
shape. It is hollow in cross section, with a relatively thin 
layer of flesh surrounding a central seed cavity filled with 
large flat seeds and pith. (Figure 3). M. Charantia consists 
the following chemical constituent charantin, diosgenin, 
gentisic acid, myristic acid and nerolidol. Momordica 
charantia is used as anthelmentic, anti-mycobacterial, 
antioxidant, antitumor, wound healing prpperties, 
antiulcer, antiviral, hypoglycemic and immune-stimulant6,7. 
 
Figure 3:  Fruit of M. Charantia 
The object of the present paper was to evaluate the wound 
healing potential of pongamia glabra, piper nigrum and 
momordica charantia. The anemic burn wound healing 
model has been utilized for the assessment of the wound 
healing potential. 
MATERIALS AND METHODS 
Plant material collection and authentication  
The fruits of Momordica charantia were collected at in the 
month of July, 2016 from local field areas of Bhopal, 
Madhya Pradesh. Leaves of Pongamia glabra collected from 
Garden and Fruits of Piper nigrum from local market. The 
specimens were submitted and identified as fruits of 
Momordica charantia (MC) family of Cucurbitaceae, leaves 
of Pongamia glabra (PG) family of Fabaceae, fruits of Piper 
nigrum (PN) family of Pipereacea and authenticated by Dr. 
Zia Ul Hassan, Department of Botany, Saifia Science College, 
Bhopal. The appression no. is 490/BS/saifia/16 has been 
preserved for future identification.  
Soxhlet Extraction 
The crude drugs were dried in shade. The moderately 
coarse powder of the drugs e.g. Momordica charantia (MC), 
Pongamia glabra (PG) and Piper nigrum (PN) were 
subjected to successive Soxhlet extraction. Soxhlet 
extraction has carried, taking 80 gm of dried coarsely 
powdered drug was packed in Soxhlet apparatus and 
defatted with 1000 ml of petroleum ether (40-60∘C) till 
complete defatted. Complete defatting ensured by placing a 
drop by thimble on the filter paper which did not exhibited 
any oily spot. The defatted material was removed from the 
Soxhlet apparatus and air dried to remove the last traces of 
petroleum ether. The defatted material was subjected to 
extraction by ethyl acetate and then with ethanol as solvent 
by Soxhlet apparatus and finally with water by maceration 
process. The completion of extract was confirmed by 
evaporating a few drops of the extract on the watch glass 
and ensuring that no residue remained after evaporating 
the solvent. 
The marc was air dried before extracted with the next 
solvent. Dried marc was macerated with water for 24 h. 
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The extracts were evaporated under reduced pressure at 
low temperature (30∘C) to dryness to yield different 
extracts, stored in an airtight container in refrigerator for 
further experimental studies. They were weighed to a 
constant weight and percentage w/w basis was calculated. 
Herbal ointment formulation and evaluation 
Herbal preparations were formulated by combination of 
three plant extract of momordica charantia, pongamia 
glabra and piper nigrum. The alcoholic and aqueous 
extracts were selected for formulation as they have the 
higher content of flavonoids and phenolic compounds. 
Preparation of Simple Ointment (B.P.) Base  
The simple ointment base was prepared by mixing the 
wool fat, hard paraffin, cetostearyl alcohol and white soft 
paraffin with gentle heating with stirring8. The obtained 
ointment base is then cooled and stored. Two formulations 
were prepared by Fusion method e.g. one containing all 
three extracts of above mentioned plants parts in equal 
ratios of alcoholic and aqueous extracts i.e. 3.33% w/w of 
each extract for the preparation of 10 % w/w ointment in 
ointment base and the other one containing all three 
extracts of above mentioned plants parts in equal ratios of 
alcoholic and aqueous extracts9 i.e. containing 5.0% w/w of 
each extract, equal to total 15% w/w in ointment base 
shown in Table 1. The prepared formulations were then 
evaluated by various parameters e.g. consistency, stability 
etc. 
Table 1: Formulation of Ointment 
S. No. Content 
Quantity (%) 
F1 F2 
1.  MCAQ (1:1) 3.33 5.0 
2.  PGAQ (1:1) 3.33 5.0 
3.  PNAQ (1:1) 3.33 5.0 
4.  Ointment base Q.S. Q.S. 
Where, MCAQ- Alcoholic and Aqueous extracts of Momordica charantia in 1:1 quantity; 
PCAQ- Alcoholic and Aqueous extracts of Pongamiaglabra in 1:1 quantity; PNAQ-
 Alcoholic and Aqueous extracts of Piper nigrum in 1:1 quantity. 
Pharmacological Activity 
Anemic wound healing activity  
Anemic burn wound model using albino rats was selected 
for assessing the wound healing potential. This model was 
employed to study the rate of wound contraction and 
tensile strength9-12. These parameters were selected and 
albino rats were selected by easy availability and simplicity 
in handling them. 
Selection and procurement of animals 
Institutional Animal Ethics Committee (IAEC), Registration 
number CPCSEA/1413/ PO/ES) has been permitted for 
animal studies. Albino rats were procured and rats of 
either sex weighing 150-200 gm were selected and 
maintained at 24-28∘C, housed individually with free access 
to food and water. They were fed with standard diet and 
kept in well-ventilated animal house with alternate dark-
light cycle of 12h throughout the studies. 
Oral toxicity studies 
Albino rats of weight 150-200gm were selected for acute 
oral toxicity study and it was conducted according to the 
“Organization for Environmental Control Development” 
guidelines (OECD: Guidelines 420; Fixed Dose Method) for 
oral administration of extracts. Eighteen hour overnight 
fasted animals were subjected to oral administration of 
extracts at a dose of 2000 mg/kg body weight. All the 
animals were kept under observation for first 3h for any 
changes or toxic effects like neurological, gross behavioral 
and lethality. The animals were observed and confirmed 
the absence of any toxic effects, hence two dose of 
combination 10% and 15% ointment were prepared with 
simple ointment base for topical application and 10 mg/ml 
oral dose taken for study. 
Sample Preparation 
Sample solutions each of 10 mg/ml of extracts was 
prepared separately and mixed so as each combination will 
contain 20 % w/v aqueous extract of Piper nigrum - PNAQ. 
Anemic Burn Wound Model 
For the anemic incision wound studies, seventy- two 
anemic albino rats were taken, divided in two main groups: 
non-anemic group (n=6) and anemic group. The anemic 
group was further divided into eleven groups of six each13. 
To perform the experiment, the rats were divided into 
Eleven groups (n=6).  
Group I: Control group which received simple vehicle 
(Ointment base) 
Group II: Standard group received Povidone iodine 
ointment 
Group III: Test group received MCAQ extract orally  
Group IV: Test group received MCAQ and PNAQ extract 
orally 
Group V: Test group received PGAQ extract orally  
Group VI: Test group received PGAQ and PNAQ extract 
orally 
Group VII: Test group received MCAQ, PGAQ and PNAQ 
orally 
Group VIII: Test group received MCAQ, PGAQ and PNAQ 
formulation F1 (10%) topically 
Group IX: Test group received MCAQ, PGAQ and PNAQ 
formulation F2 (15%) topically 
Group X: Test group received MCAQ, PGAQ and PNAQ 
orally and formulation F1 (10%) topically 
Group XI: Test group received MCAQ, PGAQ and PNAQ 
orally and formulation F2 (15%) topically 
Group XII: Anemic Group received no treatment 
Creation of Burn Wound 
Burn wounds were created on dorsal part of shaved rat's 
skin surface using concentrate sulfuric acid, exposed for 10 
s. After 24 h, dead tissues were excised using sterile 
surgical blade through a template designed to produce a 
third degree burn14. All groups were treated same as in 
excision model. In this model, wound contraction and 
epithelialization period was monitored. A specimen sample 
from the healed wound of tissue was collected from each 
rat for histopathological examination15-16. 
Hydroxyproline estimation 
Wound tissues were analyzed for hydroxyproline content, 
a basic constituent of collagen. Tissues were dried in a hot 
air oven at 60-70°C to constant weight and hydrolyzed in 6 
N HCl at 130°C for 4 h in sealed tubes. The hydrolysate was 
neutralized to pH 7 then subjected to chloramine-T 
oxidation for 20 min16. The reaction was terminated by the 
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addition of 0.4 M perchloric acid and developed color with 
Ehrlich reagent at 60°C was read at 557 nm in ultraviolet 
spectrophotometer. 
RESULTS AND DISCUSSION  
Extraction 
The extraction was done by successive solvent extraction, 
to increase the extraction, to achieve separation of 
compounds in different extracts and decrease the time 
taken by extraction process the flask and Soxhlet apparatus 
was covered by cotton to increase the insulation. The 
drying of extract containing solvent (Petroleum ether, ethyl 
acetate, ethanol and water) was done by vacuum 
distillation process. Percent yield of all extract was 
depicted in Table 2. 
 
Table 2: Percentage Yield of Different Extracts 
Parts Solvents Extract color 
Yield  
(in gm) 
% Yield w/w 
FMC 
(fruits of Momordica 
charantia) 
PFMC Yellowish green 5.54 6.93 
EFMC Brown 4.72 5.9 
AFMC Dark Brown 16.05 20.06 
QFMC Greenish brown 13.08 16.35 
LPG (leaves of 
Pongamia glabra) 
PLPG Greenish brown 1.624 2.03 
ELPG Brown 2.94 3.675 
ALPG Dark Brown 6.264 7.83 
QLPG Brownish Black 5.024 6.28 
FPN (fruits of Piper 
nigrum) 
PFPN Yellowish green 2.304 2.88 
EFPN Brown 1.664 2.08 
AFPN Dark Brown 10.158 12.698 
QFPN Greenish brown 8.904 11.13 
PFMC- Petroleum ether Extract of Momordicacharantiafruits, EFMC-Ethyl acetateExtract of Momordicacharantiafruits, AFMC- Etahnolic Extract of Momordicacharantiafruits, QFMC- 
Aqueous Extract of Momordicacharantiafruits,PLPG- Petroleum Ether Extract of Pongamiaglabraleaves, ELPG-Ethyl acetateExtract of Pongamiaglabraleaves, ALPG- Etahnolic Extract of 
Pongamiaglabraleaves, QLPG- Aqueous Extract of Pongamiaglabraleaves, PFPN- Petroleum ether Extract of Piper nigrumfruits, EFPN-Ethyl acetateExtract of Piper nigrumfruits, AFPN- 
Etahnolic Extract of Piper nigrumfruits, QFPN- Aqueous Extract of Piper nigrumfruits. 
 
Pharmacological Activity 
Wound healing activity on anemic rats 
Increased fasting blood sugar levels were observed on day 
3 after streptozotocin administration. The fasting blood 
sugars remained high throughout the study period, with a 
mean value of 14.77 ± 0.08mmol/L compared to the 
normal fasting blood sugar level, which was 6.94± 
0.52mmol/L before streptozotocin administration. The 
fasting blood sugar (FBS) levels and were estimated on 
initial and final day of experimental protocol to confirm the 
anemic state. A little change in FBS was observed. 
Increased fasting blood sugar levels were observed on day 
3 after streptozotocin administration. The fasting blood 
sugars remained high throughout the study period, with a 
mean value of 14.77 ± 0.08mmol/L compared to the 
normal fasting blood sugar level, which was 6.94± 
0.52mmol/L before streptozotocin administration. The 
fasting blood sugar levels of different groups are shown in 
Table 3 and Figure 4. 
 
Table 3: Fasting blood sugar level of experimental groups 
 
S. No. Group 
Before STZ 
induction mmol/L 
At day 3 after STZ 
Induction 
At day 10 of the 
Treatment 
1 Control 5.78±0.31 6.32±0.22 5.77±0.29 
2 GXII 5.55±0.21 18.05±2.13 21.04±2.88 
3 Standard 6.15±0.31 21.54±2.42 14.53±2.25 
4 OAQMC 7.94±3.12 15.21±0.89 15.84±3.14 
5 OAQ(MC+PN) 7.58±2.46 16.53±2.45 15.08±3.44 
6 OAQPG 8.05±2.11 15.71±3.49 16.04±4.25 
7 OAQ(PG+PN) 7.76±1.24 15.98±1.88 15.46±0.21 
8 OAQ(MC+PG+PN) 7.39±3.50 15.44±2.46 14.77±1.72 
9 TF1 7.08±1.25 14.96±2.58 14.15±2.63 
10 TF2 6.93±1.11 14.45±3.47 13.84±0.25 
11 O3TF1 6.78±3.45 14.2±3.29 13.57±1.85 
12 O3TF2 6.39±0.28 13.41±2.74 12.79±2.14 
 
Where,  AQ stands for alcoholic and aqueous extract in 1:1 amount,Group I: Control group which received simple vehicle (Ointment base), Group II: Standard group received Povidone 
iodine ointment, Group III: Test group received MC extract orally [AQMC], Group IV: Test group received MC and PN extract orally [OAQ(MC+PN)], Group V: Test group received PG 
extract orally [OAQPG], Group VI: Test group received PG and PN extract orally [OAQ(PG+PN)], Group VII: Test group received MC, PG and PN orally [OAQ(MC+PG+PN], Group VIII: 
Test group received MC, PG and PN extract formulation F1 (10%) topically [TF1], Group IX: Test group received MC, PG and PN extract  formulation F2 (15%) topically [TF2], Group X: 
Test group received MC, PG and PN orally and formulation F1 (10%) topically [O3TF1],Group XI: Test group received MC, PG  and PN orally and formulation F2 (15%) topically [O3TF2], 
Group XII: Anemic diabetic Group received no treatment [GXII] 
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Figure 4: Fasting Blood Sugar Level of Experimental Groups 
 
There is a decrease in RBC count and hemoglobin level 
after the administration of streptozotocin in negative 
control group GXII. And these levels are increased with the 
administration of test extracts and formulations of various 
selected drugs and combinations, and the P values are also 
significant. Anemic rats showed decrease in RBC count 
whereas the RBC count of the control rats remained the 
same. Administration of various extracts and combination 
of drugs significantly (P<0.001) increase the RBC count 
and brought back RBC count towards normal. 
Hematological parameters after treatment with extracts 
and formulations were tabulated in Table 5. 
  
Table 5: Hematological parameters after treatment with extracts and formulations 
S. No. Groups RBC Count (X10^12/L) Hemoglobin (g/Dl) 
1.  Control 8.76±0.65 15.82±0.59 
2.  Standard 8.13±0.53** 14.84±0.68** 
3.  OAQMC 6.21±0.42 13.2±0.56* 
4.  OAQ(MC+PN) 6.23±0.37* 13.26±0.74* 
5.  OAQPG 6.19±0.55* 13.17±0.80* 
6.  OAQ(PG+PN) 6.35±0.61* 13.43±0.89* 
7.  OAQ(MC+PG+PN) 6.77±0.70** 13.62±0.70** 
8.  TF1 6.84±0.51** 13.78±0.83** 
9.  TF2 6.98±0.64** 13.82±0.99** 
10.  O3TF1 7.88±0.80** 14.58±0.42** 
11.  O3TF2 8.04±0.23** 14.72±0.19** 
12.  GXII 6.18±0.47* 9.82±0.49* 
Note: n =6 animals in each group, values are expressed as Mean ±SEM, If *=p<0.05, **=p<0.01, ***=p<0.001 when compare to control. 
 
Anemic rats showed decrease in Hb level whereas the Hb 
level of the control rats remained the same shown in 
Figure 5. Administration of various extracts significantly 
(P<0.001) increase the Hb level and brought back Hb level 
towards normal. Streptozotocin is able to cause anemia in 
animals due to its oxidative stress. Appearance of Heinz 
bodies in red blood cell morphology proves the presence of 
anemia and it maybe a type of hemolytic anemia. 
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Figure 5: Hemoglobin (g/Dl) level after treatment with various samples 
 
Burn Wound Model17 
Wound healing activity of extract ointment formulation by 
burn wound method is represented in Table 6 and Figure 6. 
Hydroxyproline content of anemic control animals were 
decreased to significant extent in comparison to the Non- 
anemic control rat (p<0.001). The studies on burn wound 
healing model reveal that the test group (O3TF1 and 
O3TF2) showed high hydroxyproline content (stability of 
collagen) in wound area   e.g. 62.43± 0.094 mg/g and 
64.12±5.48 mg/g. The other test groups of individual drug 
ointments at different combinations has shown different 
hydroxyproline content results e.g. OAQMC and OAQ 
(MC+PN) shown 58.46±0.225 mg/g and 59.87±0.214 mg/g, 
OAQPG and OAQ (PG+PN) shown 58.64±0.134 mg/g and 
59.02±20.315 mg/g, OAQ (MC+PG+PN) shown 
60.39±0.085 mg/g, TF1 and TF2 shown 60.45±0.0112 
mg/g and 60.78±0.351 mg/g respectively. Ointment 
formulations O3TF-1 and O3TF-2 has shown significant 
hydroxyproline content activity but lesser than the oral and 
topical group, which was comparable to that of standard 
marketed preparations. The O3TF-2 group containing F2 
formulation was found more active than the O3TF1 group 
containing F-1 formulation. The hydroxyproline content is 
more when compared to standard. The control (ointment 
base) has shown 28.02±0.125 mg/g healing. 
 
Table 6: Effect of Various Samples on different parameter of Burn wound model 
S. 
No. 
Groups 
Hydroxyproline Content 
(mg/g tissue) 
Epithelialization period 
(mean time in days) 
Tensile Strength (g/mm2) 
10th day 
1 Control 28.02±0.125 18.18±0.345 473.05±6.02 
2 GXII 22.68±0.247 18.88±0.259 393.41±3.61 
3 Standard 60.41±0.352*** 15.5±0.315** 486.35±6.85* 
4 OAQMC 58.46±0.225** 17.55±0.420* 496.33±3.69* 
5 OAQ(MC+PN) 59.87±0.214** 15.97±0.318** 507.36±2.58* 
6 OAQPG 58.64±0.134** 17.75±0.249* 515.44±2.90** 
7 OAQ(PG+PN) 59.02±0.315** 16.24±0.405* 520.24±1.77** 
8 OAQ(MC+PG+PN) 60.39±0.085** 15.81±0.322** 523.72±4.41** 
9 TF1 60.45±0.112** 14.97±0.256*** 525.72±6.72** 
10 TF2 60.78±0.351** 14.77±0.207*** 530.17±5.61*** 
11 O3TF1 62.43±0.094*** 14.08±0.108*** 536.33±6.37*** 
12 O3TF2 64.12±0.107*** 13.79±0.159*** 565.78±2.89*** 
Note: n =6 animals in each group, values are expressed as Mean ±SEM, If *=p<0.05, **=p<0.01, ***=p<0.001 when compare to control. 
 
Figure 6: Effect of Various samples on Hydroxyproline content (mg/g tissue) in Burn Wound Model 
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The mean epithelialization time decreased from 18.23 days 
in controls, to 14.97 days for TF1, 14.77 days for TF-2, 
17.55 days for OAQMC, 15.97 days for OAQ (MC+PN), 17.75 
days for OAQPG, 16.24 days for OAQ (PG+PN), 15.81 days 
for OAQ (MC+PG+PN), 14.08 days for O3TF1, 13.79 days 
for O3TF2 and 18.88 days for GXII, while standard 
povidone iodine showed the lowest time of 15.50  days. 
The overall epithelialization time can be presented as: GXII 
> Control > OAQPG > OAQMC > OAQ (PG+PN)> OAQ 
(MC+PN)> OAQ (MC+PG+PN) > Standard > TF1 > TF2 > 
O3TF1 > O3TF2. Among the prepared herbal formulations, 
the blended formulation showed the decrease in 
epithelization period in comparison with controls, 
individual extracts and showed comparable results to the 
standard ointment (Figure 7). 
 
 
Figure 7: Effect of various samples on epithelialization period (mean time in days) in burn wound model 
 
The data revealed that tensile strength (skin breaking 
strength) of anemic control animals were decreased to 
significant extent in comparison to the Non-anemic control 
rats (p<0.001). The studies on burn wound healing model 
reveal that the test group (O3TF1 and O3TF2) showed high 
breaking strength in wound area from 1st day to 10th day 
e.g. 536.33±6.37g and 565.78±2.89 g. The other test groups 
of individual drug ointments at different combinations has 
shown different breaking strength results e.g. OAQMC and 
OAQ (MC+PN) shown 496.33±3.69 g and 507.362.58 g, 
OAQPG and OAQ (PG+PN) shown 515.44±2.90 g and 
520.24±1.77 g , OAQ (MC+PG+PN) shown 523.72±4.41 g , 
TF1 and TF2 shown 525.72±6.72 g and 530.17±5.61 g , 
O3TF1 and O3TF2 shown 536.33±6.37 g and 565.78±2.89 
g respectively. Ointment formulations O3TF-1 and O3TF-2 
has shown significant tensile strength activity but lesser 
than the oral and topical group, which was comparable to 
that of standard marketed preparations. The O3TF-2 group 
containing F2 formulation was found more active than the 
O3TF1 group containing F-1 formulation. The tensile 
strength is more when compared to standard. The control 
(ointment base) has shown 473.05±6.02g healing (Figure 
8) 
 
 
Figure 8: Effect of various samples on tensile strength (g/mm2) in burn wound model 
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Histopatholgical Changes  
Burn Wound Model 
 
 
Figure 9 (a-i): Histopathology of skin at day 10 stained with H&E (100X) 
 
Histopathological evaluations showed the burn healing to 
be better in the (GV, GIII, GIV, GVI, GII, GVII, GIX, GVIII, GX 
and GXI) with respect to the control group [Figure 9 (a-i)]. 
A scab formed by necrotic tissue remnants and 
mononuclear cell infiltration was present in GXII. The 
regeneration and repairing in the epidermal layer were 
also observed in various groups. Inflammatory cell 
infiltration without an epithelial layer was noticed. Vessels 
were hyper-anemic in the dermis and there were no hair 
follicles, sebaceous or sweat glands in the groups. The scab 
was thinner in the Group VIII, Group IX, Group X and Group 
XI (GIX< GVIII< GXI< GX) group. More improved epithelia 
layer formation with regeneration and repairing was 
observed. The dermal fibrosis in the subcutaneous level 
was also seen.  The epithelial layer in the Group VIII, Group 
IX, Group X and Group XI had a better appearance when 
compared to control, standard and other groups. Also, 
granulation tissue in the dermis in the (GIX< GVIII< GXI< 
GX) group was in better condition when compared with the 
other groups. The burn wound healing model also provides 
an in vivo approach for studying the healing of burn-
related wounds in domestic animals.  
 
CONCLUSION 
In the present research work ointment formulations with 
extract of three herbal drugs was prepared and evaluated 
for the anemic wound healing activity by burn wound 
model in anemic albino rat. The three individual drug 
extracts e.g. Momordica charantia fruits, Pongamia glabra 
leaves and Piper nigrum fruits has shown wound healing 
properties.  
The extracts prepared by using Soxhlet method were 
incorporated in the ointment base for formulation. Burn 
wound model utilized for the effectiveness of the three 
plants and results indicated the effectiveness of herbal 
ointment F2 show improve wound healing potential. The 
drug Momordica and Pongamia when administered orally 
and topically with piper they had shown significant 
synergistic activity. The formulation will be helpful in 
anemic wound healing with no side effects and will be 
beneficial for society and industry with standardization 
approaches.  
The present studies concluded through the burn wound 
model that wound healing property of individual drug 
extracts Momordica charantia and Pongamia glabra can be 
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enhanced by the concomitant use of Piper nigrum within 
the oral and topical formulations. The topical formulation 
containing 15% of extracts of Momordica charantia, 
Pongamia glabra and Piper nigrum in ointment formulation 
can be used as marketed formulations and its effect can be 
enhanced with intake of its oral doses besides the topical 
application. 
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